AZD2563, a new oxazolidinone: Bactericidal activity and synergy studies combined with gentamicin or vancomycin against staphylococci and streptococcal strains

Diagnostic Microbiology and Infectious Disease

Volumn 43, Issue 1, 2002, Pages 87-90

  Jones, R N ^a   Anderegg, T R ^a   Deshpande, L M ^b  

^a JONES Group JMI Laboratories   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN; OXAZOLIDINONE DERIVATIVE; POSIZOLID; UNCLASSIFIED DRUG; VANCOMYCIN;

ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; BETA HEMOLYTIC STREPTOCOCCUS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENTIATION; DRUG SCREENING; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS; STRAIN DIFFERENCE; STREPTOCOCCUS;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; GENTAMICINS; MICROBIAL SENSITIVITY TESTS; OXAZOLIDINONES; STAPHYLOCOCCUS; STREPTOCOCCUS; TIME FACTORS; VANCOMYCIN;

EID: 0036276212     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(02)00360-7     Document Type: Article

References (16)

1. Anti-streptococcal activity of AZD2563 a new oxazolidinone antimicrobial agent
2. The new oxazolidinone, AZD2563: Physiologically-based pharmacokinetic extrapolation to man
3. Novelies in the field of anti-infective compounds in 1999
4. Pharmacodynamic characteristics of AZD2563, the new oxazolidinone, in a murine thigh-infection model
5. Oxazolidinones: A review
6. Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid
7. Susceptibility of a variety of clinical isolates to linezolid: A European inter-country comparison
8. In vivo studies of novel oxazolidinones with O- and N-linked C-5 heterocyclic side-chains, including AZD2563
9. In vitro activity of a novel oxazolidinone, AZD2563, against Gram-positive cocci, including diverse multi-resistant isolates
10. In vitro antimicrobial activity of AZD2563, a novel oxazolidinone, tested against Staphylococcus aureus and coagulase-negative staphylococci
11. In vitro antimicrobial activity and spectrum of U-100592 and U-100766, two novel fluorinated oxazolidinones
12. Linezolid. A review of the first oxazolidinone
13. In vitro activity of AZD2563, the new oxazolidinone, against clinical isolates of Gram-positive cocci, including multi-resistant strains
14. Linezolid resistance in a clinical isolate of Staphylococcus aureus
15. Investigations into the antibacterial spectrum of the new oxazolidinone, AZD2563, against recent clinical isolates from North America and Europe